Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia
- PMID: 18973730
- DOI: 10.1007/s11916-008-0067-5
Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia
Abstract
A flurry of recent randomized, placebo-controlled trials assessing dissimilar pharmacotherapeutic treatment options for fibromyalgia (FM) have been presented in the past few years. This review evaluates these trials in light of recent pathophysiological concepts germane to FM, including mood disorders, autonomic dysregulation, altered sleep stage architecture, and the diagnostic tender point controversy. Studies with gabapentin, pregabalin, duloxetine, milnacipran, sodium oxybate, and pramipexole for treatment of FM are discussed.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous